Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?
Biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) has made for a solid investment over the past decade, more than quadrupling in value during that period. The stock generated fantastic returns for investors and this year it's also up around 20% as there's still ample bullishness around the business. The company is a leader in cystic fibrosis treatments with an eye for more growth and diversification in the long run.
Does Vertex have the potential to be a millionaire-making investment going forward?
The challenge for Vertex Pharmaceuticals will be to keep its growth rate strong. For the quarter ending June 30, the company's sales totaled $2.5 billion and were up 14% year over year. That revenue comes mainly from cystic fibrosis products, specifically Trikafta/Kaftrio, which generated over $2.2 billion.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
Starke Kaufneigung bei Vertex Pharmaceuticals Inc., mit mehr Buy- als Sell-Einschätzungen.
Ein positives, wenn auch bescheidenes, Potenzial für Vertex Pharmaceuticals Inc. mit einem Kursziel von 459 € im Vergleich zum aktuellen Kurs von 436.05 €.
